RNS Number : 5146U
Vianet Group PLC
12 July 2018
12 July 2018
Vianet Group PLC
(the "Company")
Director/PDMR Shareholding
The Company today announces that on 12 July 2018, David Coplin, Non-Executive Director of the Company, purchased 3,000 ordinary shares of 10 pence each in the capital of the company ("Ordinary Shares"), at a purchase price of £1.182 per Ordinary Share.
Following this purchase, Mr Coplin holds 3,000 Ordinary Shares representing approximately 0.01% per cent of the Company's issued share capital.
The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a)
|
Name
|
David Coplin
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-Executive Director
|
|
b)
|
Initial notification /Amendment
|
Initial
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Vianet Group PLC
|
|
b)
|
LEI
|
2138007KAM1HB8E7E134
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary Shares of 10 pence each
ISIN: GB00B13YVN56
|
|
b)
|
Nature of the transaction
|
Purchase of Ordinary Shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
£1.182 per share
|
3,000
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction
|
|
e)
|
Date of the transaction
|
12 July 2018
|
|
f)
|
Place of the transaction
|
London Stock Exchange, XLON
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHFKBDBABKDKOD